Fenwick, Cooley Steer Lycia Therapeutics' Upsized $318M IPO
Early-stage biotechnology firm Lycia Therapeutics began trading Friday after raising $318 million in its upsized initial public offering steered by Fenwick & West LLP and Cooley LLP....To view the full article, register now.
Already a subscriber? Click here to view full article